X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hema6 (30) 30
humans (30) 30
index medicus (29) 29
oncology (28) 28
female (25) 25
male (25) 25
original reports (25) 25
middle aged (24) 24
aged (22) 22
adult (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
treatment outcome (17) 17
hema5 (15) 15
rituximab (11) 11
aged, 80 and over (10) 10
drug administration schedule (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
leukemia, lymphocytic, chronic, b-cell - drug therapy (9) 9
young adult (9) 9
cancer (8) 8
hema7 (8) 8
therapy (7) 7
adolescent (6) 6
antineoplastic agents - therapeutic use (6) 6
cytarabine - administration & dosage (6) 6
kaplan-meier estimate (6) 6
leukemia, myeloid, acute - drug therapy (6) 6
prognosis (6) 6
antibodies, monoclonal, murine-derived - administration & dosage (5) 5
cyclophosphamide (5) 5
cyclophosphamide - administration & dosage (5) 5
disease-free survival (5) 5
drug resistance, neoplasm (5) 5
hema9 (5) 5
initial therapy (5) 5
remission induction (5) 5
trial (5) 5
vidarabine - administration & dosage (5) 5
vidarabine - analogs & derivatives (5) 5
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal, murine-derived - adverse effects (4) 4
antineoplastic agents - administration & dosage (4) 4
cells (4) 4
child (4) 4
hema8 (4) 4
hematopoietic stem cell transplantation (4) 4
leukemia, lymphocytic, chronic, b-cell - mortality (4) 4
mutation (4) 4
myelodysplastic syndromes - drug therapy (4) 4
recurrence (4) 4
regimen (4) 4
thalidomide - adverse effects (4) 4
thalidomide - analogs & derivatives (4) 4
united states (4) 4
acute myeloid-leukemia (3) 3
alemtuzumab (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal, murine-derived (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
bone1 (3) 3
dose-response relationship, drug (3) 3
faze (3) 3
follow-up studies (3) 3
hema4 (3) 3
leukemia, lymphocytic, chronic, b-cell - genetics (3) 3
lymphoma (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
neoplasms (3) 3
pedi3 (3) 3
pyridines - administration & dosage (3) 3
review (3) 3
review articles (3) 3
risk factors (3) 3
survival analysis (3) 3
survival rate (3) 3
thalidomide - administration & dosage (3) 3
time factors (3) 3
to19 (3) 3
untreated patients (3) 3
1st-line therapy (2) 2
acute lymphocytic-leukemia (2) 2
acute myelogenous leukemia (2) 2
age factors (2) 2
anemia - chemically induced (2) 2
antibodies, monoclonal, humanized (2) 2
antibodies, neoplasm - administration & dosage (2) 2
antibodies, neoplasm - adverse effects (2) 2
apoptosis (2) 2
azacitidine - administration & dosage (2) 2
azacitidine - adverse effects (2) 2
bc6 (2) 2
benzamides (2) 2
benzenesulfonates - administration & dosage (2) 2
bios3 (2) 2
chemotherapy (2) 2
child, preschool (2) 2
chlorambucil (2) 2
chlorambucil - administration & dosage (2) 2
chromosome aberrations (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 33, pp. 4098 - 4103
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1242 - 1248
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2010, Volume 28, Issue 24, pp. 3880 - 3889
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 17, pp. 2410 - 2415
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 584 - 591
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2514 - 2520
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 24, pp. 3293 - 3300
Journal Article
Journal Article